Global Deep Learning In Drug Discovery And Diagnostics Market Report 2024

Deep Learning In Drug Discovery And Diagnostics Global Market Report 2025 – By Type (Drug Discovery, Diagnostics, Forensic Interventions, Other Types), By Drug Type (Small Molecule Drugs, Biologics Drugs), By End Use Industry (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Healthcare Information Technology (IT)) – Market Size, Trends, And Global Forecast 2025-2034

Deep Learning In Drug Discovery And Diagnostics Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Deep Learning In Drug Discovery And Diagnostics Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Deep Learning In Drug Discovery And Diagnostics Market Definition

Deep learning in drug discovery and diagnostics refers to the use of advanced neural networks and artificial intelligence (AI) techniques to analyze complex biological and chemical data for predicting drug interactions, identifying disease patterns, and enhancing personalized medicine. Deep learning enhances drug discovery and diagnostics by improving prediction accuracy, automating data processing, and enabling personalized medicine through advanced analysis of complex biological and chemical data.

The main types of deep learning in drug discovery and diagnostics are drug discovery, diagnostics, forensic interventions, and others. Drug discovery involves using deep learning algorithms to analyze biological data and predict which drug compounds will be effective. These algorithms can speed up the process by identifying promising drug candidates and potential side effects earlier in the research phase. The drug types are small-molecule drugs and biologic drugs, and they are used by various end-use industries such as pharmaceutical companies, biotechnology companies, contract research organizations (CROs), and healthcare information technology (IT).

Deep Learning In Drug Discovery And Diagnostics Market Segmentation

The deep learning in drug discovery and diagnosticsmarket covered in this report is segmented –

1) By Type: Drug Discovery, Diagnostics, Forensic Interventions, Other Types

2) By Drug Type: Small Molecule Drugs, Biologics Drugs

3) By End Use Industry: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Healthcare Information Technology (IT)

Subsegments:

1) By Drug Discovery: Target Identification, drug screening, Lead Optimization, Predictive Modeling

2) By Diagnostics: Medical Imaging Analysis, Genomic Data Interpretation, Disease Detection Algorithms, Personalized Medicine

3) By Forensic Interventions: digital pathology, Forensic DNA Analysis, Toxicology Screening, Crime Scene Reconstruction

4) By Other Types: Biomarker Discovery, Predictive Analytics in Healthcare, Patient Data Management Systems

Deep Learning In Drug Discovery And Diagnostics Market Size and growth rate 2025 to 2029: Graph

Deep Learning In Drug Discovery And Diagnostics Market Size 2025 And Growth Rate

The deep learning in drug discovery and diagnostics market size has grown exponentially in recent years. It will grow from $8.21 billion in 2024 to $10.58 billion in 2025 at a compound annual growth rate (CAGR) of 28.8%. The growth in the historic period can be attributed to increased investment in AI research, growing demand for personalized medicine, increased funding from public and private sectors, rise in chronic diseases and complex conditions, and growing adoption of electronic health records.

Deep Learning In Drug Discovery And Diagnostics Market Growth Forecast

The deep learning in drug discovery and diagnostics market size is expected to see exponential growth in the next few years. It will grow to $28.82 billion in 2029 at a compound annual growth rate (CAGR) of 28.5%. The growth in the forecast period can be attributed to improved diagnostic accuracy, growing collaboration between tech companies and pharmaceutical firms, progress in explainable AI (xai) for better model transparency, increased emphasis on real-world evidence (RWE), and expansion into emerging markets. Major trends in the forecast period include the adoption of AI technologies, advancements in computational power, integration of big data, development of novel deep learning architectures, and expansion of cloud-based platforms for AI.

Deep Learning In Drug Discovery And Diagnostics Market Driver: Rising Demand For Personalized Medicine Fuels Growth In Deep Learning In Drug Discovery And Diagnostics

The growing demand for personalized medicine is expected to propel the growth of deep learning in drug discovery and diagnostics market going forward. Personalized medicine tailors medical treatment and interventions to individual genetic, environmental, and lifestyle factors to optimize efficacy and minimize side effects. The growing demand for personalized medicine is driven by advancements in genomics and data analytics, which enable more precise and effective treatments based on individual patient profiles. Deep learning in drug discovery and diagnostics enhances personalized medicine by analyzing complex biological data to identify unique biomarkers and predict patient responses to treatments more accurately. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the growing demand for personalized medicine drives deep learning in drug discovery and diagnostics market.

Global Deep Learning In Drug Discovery And Diagnostics Market Major Players

Major companies operating in the deep learning in drug discovery and diagnostics market are Google Inc., Microsoft Corporation, International Business Machines Corporation, NVIDIA Corporation, Zebra Medical Vision Ltd., Tempus Labs Inc., Nanostring Technologies Inc., Owkin Inc., Insilico Medicine Inc., SOPHiA GENETICS SA, Qureai Technologies Pvt Ltd., H2Oai Inc., Arterys Inc., Deep Genomics Inc., GNS Healthcare Inc., MedAware Systems Inc., PathAI Inc., Kheiron Medical Technologies Ltd., CureMetrix Inc., OncoImmunity AS, Proscia Inc., BenevolentAI Ltd., BioXcel Therapeutics Inc.

Global Deep Learning In Drug Discovery And Diagnostics Market Trend: New Supercomputers Boost AI Capabilities In Drug Discovery And Diagnostics

Major companies operating in the deep learning in drug discovery and diagnostics market are focusing on the advancement of high-performance computing technologies, such as supercomputers, to accelerate innovation through improved performance and efficiency in complex tasks and AI applications. Advancements in supercomputers enhance deep learning in drug discovery and diagnostics by speeding up complex data analysis and simulations, leading to faster identification of drug candidates and more accurate diagnostics. For instance, in November 2022, Hewlett-Packard Enterprise, a US-based information technology company, introduced the HPE Cray EX and HPE Cray XD supercomputers. These new systems offer powerful performance and AI-at-scale capabilities in a more compact and cost-efficient design, aimed at accelerating drug discovery and speeding up disease treatments. This enables research scientists and pharmaceutical labs to gain deeper insights into chemical interactions, fostering the development of innovative drug therapies for both challenging and newly emerging diseases.

Deep Learning In Drug Discovery And Diagnostics Market Merger And Acquisition: Ginkgo Bioworks Acquires Reverie Labs To Advance AI-Driven Drug Discovery

In February 2024, Ginkgo Bioworks Holdings Inc., a US-based biotech company that specializes in using genetic engineering acquired Reverie Labs key assets for an undisclosed amount. Through the acquisition of Reverie's infrastructure and software for training large-scale AI foundation models, Ginkgo aims to enhance its AI or ML-driven discovery services and accelerate its efforts to develop next-generation biological foundation models. Reverie Labs Inc. is a US-based company that built and used AI or ML tools to accelerate drug discovery.

Regional Outlook For The Global Deep Learning In Drug Discovery And Diagnostics Market

North America was the largest region in the deep learning in drug discovery and diagnostics market in 2024. The regions covered in the deep learning in drug discovery and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the deep learning in drug discovery and diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Deep Learning In Drug Discovery And Diagnostics Market?

The deep learning in drug discovery and diagnostics market consists of revenues earned by entities by providing services such as developing and integrating deep learning algorithms, analyzing large-scale biological and chemical data, offering software solutions and platforms, and consulting on AI-driven drug discovery and diagnostic strategies. The market value includes the value of related goods sold by the service provider or included within the service offering. The deep learning in drug discovery and diagnostics market also includes sales of software platforms and tools, machine learning frameworks, data analytics solutions, cloud-based computing services, hardware accelerators, and AI-driven diagnostic devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Deep Learning In Drug Discovery And Diagnostics Industry?

The deep learning in drug discovery and diagnostics market research report is one of a series of new reports from The Business Research Company that provides deep learning in drug discovery and diagnostics market statistics, including deep learning in drug discovery and diagnostics industry global market size, regional shares, competitors with a deep learning in drug discovery and diagnostics market share, detailed deep learning in drug discovery and diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the deep learning in drug discovery and diagnostics industry. This deep learning in drug discovery and diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Deep Learning In Drug Discovery And Diagnostics Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $10.58 billion
Revenue Forecast In 2034 $28.82 billion
Growth Rate CAGR of 28.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Drug Discovery, Diagnostics, Forensic Interventions, Other Types
2) By Drug Type: Small Molecule Drugs, Biologics Drugs
3) By End Use Industry: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Healthcare Information Technology (IT) Subsegments: 1) By Drug Discovery: Target Identification, Drug Screening, Lead Optimization, Predictive Modeling
2) By Diagnostics: Medical Imaging Analysis, Genomic Data Interpretation, Disease Detection Algorithms, Personalized Medicine
3) By Forensic Interventions: Digital Pathology, Forensic DNA Analysis, Toxicology Screening, Crime Scene Reconstruction
4) By Other Types: Biomarker Discovery, Predictive Analytics in Healthcare, Patient Data Management Systems
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Google Inc., Microsoft Corporation, International Business Machines Corporation, NVIDIA Corporation, Zebra Medical Vision Ltd, Tempus Labs Inc., Nanostring Technologies Inc., Owkin Inc., Insilico Medicine Inc., SOPHiA GENETICS SA, Qureai Technologies Pvt Ltd, H2Oai Inc., Arterys Inc., Deep Genomics Inc., GNS Healthcare Inc., MedAware Systems Inc., PathAI Inc., Kheiron Medical Technologies Ltd, CureMetrix Inc., OncoImmunity AS, Proscia Inc., BenevolentAI Ltd, BioXcel Therapeutics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Deep Learning In Drug Discovery And Diagnostics Market Characteristics

    3. Deep Learning In Drug Discovery And Diagnostics Market Trends And Strategies

    4. Deep Learning In Drug Discovery And Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Deep Learning In Drug Discovery And Diagnostics Growth Analysis And Strategic Analysis Framework

    5.1. Global Deep Learning In Drug Discovery And Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Deep Learning In Drug Discovery And Diagnostics Market Growth Rate Analysis

    5.4. Global Deep Learning In Drug Discovery And Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Deep Learning In Drug Discovery And Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Deep Learning In Drug Discovery And Diagnostics Total Addressable Market (TAM)

    6. Deep Learning In Drug Discovery And Diagnostics Market Segmentation

    6.1. Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Drug Discovery

    Diagnostics

    Forensic Interventions

    Other Types

    6.2. Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Small Molecule Drugs

    Biologics Drugs

    6.3. Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Pharmaceutical Companies

    Biotechnology Companies

    Contract Research Organizations (CROs)

    Healthcare Information Technology (IT)

    6.4. Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Drug Discovery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Target Identification

    Drug Screening

    Lead Optimization

    Predictive Modeling

    6.5. Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Medical Imaging Analysis

    Genomic Data Interpretation

    Disease Detection Algorithms

    Personalized Medicine

    6.6. Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Forensic Interventions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Digital Pathology

    Forensic DNA Analysis

    Toxicology Screening

    Crime Scene Reconstruction

    6.7. Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Biomarker Discovery

    Predictive Analytics in Healthcare

    Patient Data Management Systems

    7. Deep Learning In Drug Discovery And Diagnostics Market Regional And Country Analysis

    7.1. Global Deep Learning In Drug Discovery And Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Deep Learning In Drug Discovery And Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market

    8.1. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Deep Learning In Drug Discovery And Diagnostics Market

    9.1. China Deep Learning In Drug Discovery And Diagnostics Market Overview

    9.2. China Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Deep Learning In Drug Discovery And Diagnostics Market

    10.1. India Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Deep Learning In Drug Discovery And Diagnostics Market

    11.1. Japan Deep Learning In Drug Discovery And Diagnostics Market Overview

    11.2. Japan Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Deep Learning In Drug Discovery And Diagnostics Market

    12.1. Australia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Deep Learning In Drug Discovery And Diagnostics Market

    13.1. Indonesia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Deep Learning In Drug Discovery And Diagnostics Market

    14.1. South Korea Deep Learning In Drug Discovery And Diagnostics Market Overview

    14.2. South Korea Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Deep Learning In Drug Discovery And Diagnostics Market

    15.1. Western Europe Deep Learning In Drug Discovery And Diagnostics Market Overview

    15.2. Western Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Deep Learning In Drug Discovery And Diagnostics Market

    16.1. UK Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Deep Learning In Drug Discovery And Diagnostics Market

    17.1. Germany Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Deep Learning In Drug Discovery And Diagnostics Market

    18.1. France Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Deep Learning In Drug Discovery And Diagnostics Market

    19.1. Italy Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Deep Learning In Drug Discovery And Diagnostics Market

    20.1. Spain Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market

    21.1. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market Overview

    21.2. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Deep Learning In Drug Discovery And Diagnostics Market

    22.1. Russia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Deep Learning In Drug Discovery And Diagnostics Market

    23.1. North America Deep Learning In Drug Discovery And Diagnostics Market Overview

    23.2. North America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Deep Learning In Drug Discovery And Diagnostics Market

    24.1. USA Deep Learning In Drug Discovery And Diagnostics Market Overview

    24.2. USA Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Deep Learning In Drug Discovery And Diagnostics Market

    25.1. Canada Deep Learning In Drug Discovery And Diagnostics Market Overview

    25.2. Canada Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Deep Learning In Drug Discovery And Diagnostics Market

    26.1. South America Deep Learning In Drug Discovery And Diagnostics Market Overview

    26.2. South America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Deep Learning In Drug Discovery And Diagnostics Market

    27.1. Brazil Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Deep Learning In Drug Discovery And Diagnostics Market

    28.1. Middle East Deep Learning In Drug Discovery And Diagnostics Market Overview

    28.2. Middle East Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Deep Learning In Drug Discovery And Diagnostics Market

    29.1. Africa Deep Learning In Drug Discovery And Diagnostics Market Overview

    29.2. Africa Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Deep Learning In Drug Discovery And Diagnostics Market Competitive Landscape And Company Profiles

    30.1. Deep Learning In Drug Discovery And Diagnostics Market Competitive Landscape

    30.2. Deep Learning In Drug Discovery And Diagnostics Market Company Profiles

    30.2.1. Google Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. International Business Machines Corporation (IBM) Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Zebra Medical Vision Ltd Overview, Products and Services, Strategy and Financial Analysis

    31. Deep Learning In Drug Discovery And Diagnostics Market Other Major And Innovative Companies

    31.1. Tempus Labs Inc.

    31.2. Nanostring Technologies Inc.

    31.3. Owkin Inc.

    31.4. Insilico Medicine Inc.

    31.5. SOPHiA GENETICS SA

    31.6. Qureai Technologies Pvt Ltd

    31.7. H2Oai Inc.

    31.8. Arterys Inc.

    31.9. Deep Genomics Inc.

    31.10. GNS Healthcare Inc.

    31.11. MedAware Systems Inc.

    31.12. PathAI Inc.

    31.13. Kheiron Medical Technologies Ltd

    31.14. CureMetrix Inc.

    31.15. OncoImmunity AS

    32. Global Deep Learning In Drug Discovery And Diagnostics Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Deep Learning In Drug Discovery And Diagnostics Market

    34. Recent Developments In The Deep Learning In Drug Discovery And Diagnostics Market

    35. Deep Learning In Drug Discovery And Diagnostics Market High Potential Countries, Segments and Strategies

    35.1 Deep Learning In Drug Discovery And Diagnostics Market In 2029 - Countries Offering Most New Opportunities

    35.2 Deep Learning In Drug Discovery And Diagnostics Market In 2029 - Segments Offering Most New Opportunities

    35.3 Deep Learning In Drug Discovery And Diagnostics Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Drug Discovery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Forensic Interventions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Deep Learning In Drug Discovery And Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Deep Learning In Drug Discovery And Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Google Inc. Financial Performance
  • Table 79: Microsoft Corporation Financial Performance
  • Table 80: International Business Machines Corporation (IBM) Financial Performance
  • Table 81: NVIDIA Corporation Financial Performance
  • Table 82: Zebra Medical Vision Ltd Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Drug Discovery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Forensic Interventions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Deep Learning In Drug Discovery And Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Deep Learning In Drug Discovery And Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Google Inc. Financial Performance
  • Figure 79: Microsoft Corporation Financial Performance
  • Figure 80: International Business Machines Corporation (IBM) Financial Performance
  • Figure 81: NVIDIA Corporation Financial Performance
  • Figure 82: Zebra Medical Vision Ltd Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Deep Learning In Drug Discovery And Diagnostics market?

Deep learning in drug discovery and diagnostics refers to the use of advanced neural networks and artificial intelligence (AI) techniques to analyze complex biological and chemical data for predicting drug interactions, identifying disease patterns, and enhancing personalized medicine. Deep learning enhances drug discovery and diagnostics by improving prediction accuracy, automating data processing, and enabling personalized medicine through advanced analysis of complex biological and chemical data. For further insights on the Deep Learning In Drug Discovery And Diagnostics market, request a sample here

How will the Deep Learning In Drug Discovery And Diagnostics market drivers and restraints affect the market dynamics? What forces will shape the Deep Learning In Drug Discovery And Diagnostics industry going forward?

The Deep Learning In Drug Discovery And Diagnostics market major growth driver - Rising Demand For Personalized Medicine Fuels Growth In Deep Learning In Drug Discovery And Diagnostics. For further insights on the Deep Learning In Drug Discovery And Diagn request a sample here

What is the forecast market size or the forecast market value of the Deep Learning In Drug Discovery And Diagnostics market?

The Deep Learning In Drug Discovery And Diagnostics market size has grown strongly in recent years. The deep learning in drug discovery and diagnostics market size has grown exponentially in recent years. It will grow from $8.21 $ billion in 2024 to $10.58 $ billion in 2025 at a compound annual growth rate (CAGR) of 28.8%. The growth in the historic period can be attributed to increased investment in AI research, growing demand for personalized medicine, increased funding from public and private sectors, rise in chronic diseases and complex conditions, and growing adoption of electronic health records. The deep learning in drug discovery and diagnostics market size is expected to see exponential growth in the next few years. It will grow to $28.82 $ billion in 2029 at a compound annual growth rate (CAGR) of 28.5%. The growth in the forecast period can be attributed to improved diagnostic accuracy, growing collaboration between tech companies and pharmaceutical firms, progress in explainable AI (xai) for better model transparency, increased emphasis on real-world evidence (RWE), and expansion into emerging markets. Major trends in the forecast period include the adoption of AI technologies, advancements in computational power, integration of big data, development of novel deep learning architectures, and expansion of cloud-based platforms for AI. For further insights on the Deep Learning In Drug Discovery And Diagnostics market, request a sample here

How is the Deep Learning In Drug Discovery And Diagnostics market segmented?

The deep learning in drug discovery and diagnosticsmarket covered in this report is segmented –
1) By Type: Drug Discovery, Diagnostics, Forensic Interventions, Other Types
2) By Drug Type: Small Molecule Drugs, Biologics Drugs
3) By End Use Industry: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Healthcare Information Technology (IT)
Subsegments:
1) By Drug Discovery: Target Identification, Drug Screening, Lead Optimization, Predictive Modeling
2) By Diagnostics: Medical Imaging Analysis, Genomic Data Interpretation, Disease Detection Algorithms, Personalized Medicine
3) By Forensic Interventions: Digital Pathology, Forensic DNA Analysis, Toxicology Screening, Crime Scene Reconstruction
4) By Other Types: Biomarker Discovery, Predictive Analytics in Healthcare, Patient Data Management Systems For further insights on the Deep Learning In Drug Discovery And Diagnostics market,
request a sample here

Which region has the largest share of the Deep Learning In Drug Discovery And Diagnostics market? What are the other regions covered in the report?

North America was the largest region in the deep learning in drug discovery and diagnostics market in 2024. The regions covered in the deep learning in drug discovery and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Deep Learning In Drug Discovery And Diagnostics market, request a sample here.

Who are the major players in the Deep Learning In Drug Discovery And Diagnostics market?

Major companies operating in the deep learning in drug discovery and diagnostics market are Google Inc., Microsoft Corporation, International Business Machines Corporation, NVIDIA Corporation, Zebra Medical Vision Ltd., Tempus Labs Inc., Nanostring Technologies Inc., Owkin Inc., Insilico Medicine Inc., SOPHiA GENETICS SA, Qureai Technologies Pvt Ltd., H2Oai Inc., Arterys Inc., Deep Genomics Inc., GNS Healthcare Inc., MedAware Systems Inc., PathAI Inc., Kheiron Medical Technologies Ltd., CureMetrix Inc., OncoImmunity AS, Proscia Inc., BenevolentAI Ltd., BioXcel Therapeutics Inc. . For further insights on the Deep Learning In Drug Discovery And Diagnostics market, request a sample here.

What are the key trends in the Deep Learning In Drug Discovery And Diagnostics market?

Major trends in the Deep Learning In Drug Discovery And Diagnostics market include New Supercomputers Boost AI Capabilities In Drug Discovery And Diagnostics. For further insights on the Deep Learning In Drug Discovery And Diagnostics market, request a sample here.

What are the major opportunities in the Deep Learning In Drug Discovery And Diagnostics market? What are the strategies for the Deep Learning In Drug Discovery And Diagnostics market?

For detailed insights on the major opportunities and strategies in the Deep Learning In Drug Discovery And Diagnostics market, request a sample here.

How does the Deep Learning In Drug Discovery And Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Deep Learning In Drug Discovery And Diagnostics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Deep Learning In Drug Discovery And Diagnostics industry?

For detailed insights on the mergers and acquisitions in the Deep Learning In Drug Discovery And Diagnostics industry, request a sample here.

What are the key dynamics influencing the Deep Learning In Drug Discovery And Diagnostics market growth? SWOT analysis of the Deep Learning In Drug Discovery And Diagnostics market.

For detailed insights on the key dynamics influencing the Deep Learning In Drug Discovery And Diagnostics market growth and SWOT analysis of the Deep Learning In Drug Discovery And Diagnostics industry, request a sample here.